- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x CD: CADMIUM ION(Non-covalent)
CD.2: 5 residues within 4Å:- Chain A: C.11, H.185, E.222, D.233
- Ligands: PEZ.3
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:C.11, A:H.185, A:E.222, A:D.233, H2O.6
CD.5: 6 residues within 4Å:- Chain B: C.11, K.46, H.185, E.222, D.233
- Ligands: PEZ.6
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:C.11, B:H.185, B:E.222, B:E.222, B:D.233
CD.8: 5 residues within 4Å:- Chain C: C.11, H.185, E.222, D.233
- Ligands: PEZ.9
5 PLIP interactions:4 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:C.11, C:H.185, C:E.222, C:D.233, H2O.17
CD.11: 6 residues within 4Å:- Chain D: C.11, K.46, H.185, E.222, D.233
- Ligands: PEZ.12
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:C.11, D:H.185, D:E.222, D:E.222, D:D.233
- 4 x PEZ: 2-(PHOSPHONOOXY)BUTANOIC ACID(Non-covalent)
PEZ.3: 13 residues within 4Å:- Chain A: K.41, S.43, K.46, N.48, D.81, Q.99, P.101, A.102, K.124, R.154, H.185, F.220
- Ligands: CD.2
14 PLIP interactions:14 interactions with chain A- Hydrogen bonds: A:S.43, A:D.81, A:A.102
- Water bridges: A:N.48, A:F.103, A:R.154, A:R.154
- Salt bridges: A:K.41, A:K.46, A:K.124, A:K.124, A:R.154, A:H.185, A:H.185
PEZ.6: 14 residues within 4Å:- Chain B: K.41, S.43, K.46, N.48, D.81, Q.99, P.101, A.102, K.124, R.154, H.185, F.220, E.222
- Ligands: CD.5
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:S.43, B:S.43, B:A.102
- Water bridges: B:F.103, B:R.154
- Salt bridges: B:K.41, B:K.46, B:K.124, B:K.124, B:R.154, B:H.185, B:H.185
PEZ.9: 13 residues within 4Å:- Chain C: K.41, S.43, K.46, N.48, D.81, Q.99, P.101, A.102, K.124, R.154, H.185, F.220
- Ligands: CD.8
15 PLIP interactions:15 interactions with chain C- Hydrogen bonds: C:S.43, C:D.81, C:A.102
- Water bridges: C:N.48, C:D.81, C:F.103, C:R.154, C:R.154
- Salt bridges: C:K.41, C:K.46, C:K.124, C:K.124, C:R.154, C:H.185, C:H.185
PEZ.12: 14 residues within 4Å:- Chain D: K.41, S.43, K.46, N.48, D.81, Q.99, P.101, A.102, K.124, R.154, H.185, F.220, E.222
- Ligands: CD.11
12 PLIP interactions:12 interactions with chain D- Hydrogen bonds: D:S.43, D:S.43, D:A.102
- Water bridges: D:F.103, D:R.154
- Salt bridges: D:K.41, D:K.46, D:K.124, D:K.124, D:R.154, D:H.185, D:H.185
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xu, X. et al., Structure-Based Design of Novel Inhibitors of 3-Deoxy-D-manno-octulosonate 8-Phosphate Synthase. DRUG DES.DISCOVERY (2003)
- Release Date
- 2004-02-17
- Peptides
- 2-dehydro-3-deoxyphosphooctonate aldolase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x CD: CADMIUM ION(Non-covalent)
- 4 x PEZ: 2-(PHOSPHONOOXY)BUTANOIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xu, X. et al., Structure-Based Design of Novel Inhibitors of 3-Deoxy-D-manno-octulosonate 8-Phosphate Synthase. DRUG DES.DISCOVERY (2003)
- Release Date
- 2004-02-17
- Peptides
- 2-dehydro-3-deoxyphosphooctonate aldolase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B